Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin S Channer

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
JAMA|March 6, 2014
Deaths and cardiovascular events in men receiving testosteroneT Hugh Jones, Kevin S Channer
Postgraduate Medical Journal|November 25, 2010
Reversible heart failure: the role of inflammatory activationTim Robinson, Alyson Smith, Kevin S Channer
Postgraduate Medical Journal|June 30, 2012
Reversible heart failure: toxins, tachycardiomyopathy and mitochondrial abnormalitiesPaul D Morris, Tim Robinson, Kevin S Channer
The Journal of Clinical Endocrinology and Metabolism|May 9, 2017
Letter to the Editor: "Effects of Testosterone Replacement on Electrocardiographic Parameters in Men: Findings From Two Randomized Trials"Janice B Schwartz, Giuseppe Rosano, Kevin S Channer
Diabetes & Vascular Disease Research|June 10, 2008
Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetesDheeraj Kapoor, Kevin S Channer, T Hugh Jones
European Heart Journal|April 26, 2003
Acute haemodynamic effects of testosterone in men with chronic heart failurePeter J Pugh, T Hugh Jones, Kevin S Channer
European Journal of Heart Failure|July 11, 2006
The effect of testosterone on insulin sensitivity in men with heart failureChris J Malkin, T Hugh Jones, Kevin S Channer
American Heart Journal|February 26, 2003
Cytomegalovirus seropositivity, infectious burden, and coronary artery diseasePeter J Pugh, Christopher J Malkin, Kevin S Channer
Thorax|November 3, 2012
Focal pulmonary oedema: an unusual presentation of acute mitral regurgitationPaul D Morris, David R Warriner, Kevin S Channer
Nature|November 27, 2004
Replacement therapy, not recreational tonicRichard D Jones, T Hugh Jones, Kevin S Channer
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
JAMA|March 6, 2014
Deaths and cardiovascular events in men receiving testosteroneT Hugh Jones, Kevin S Channer
Postgraduate Medical Journal|November 25, 2010
Reversible heart failure: the role of inflammatory activationTim Robinson, Alyson Smith, Kevin S Channer
Postgraduate Medical Journal|June 30, 2012
Reversible heart failure: toxins, tachycardiomyopathy and mitochondrial abnormalitiesPaul D Morris, Tim Robinson, Kevin S Channer
The Journal of Clinical Endocrinology and Metabolism|May 9, 2017
Letter to the Editor: "Effects of Testosterone Replacement on Electrocardiographic Parameters in Men: Findings From Two Randomized Trials"Janice B Schwartz, Giuseppe Rosano, Kevin S Channer
Diabetes & Vascular Disease Research|June 10, 2008
Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetesDheeraj Kapoor, Kevin S Channer, T Hugh Jones
European Heart Journal|April 26, 2003
Acute haemodynamic effects of testosterone in men with chronic heart failurePeter J Pugh, T Hugh Jones, Kevin S Channer
European Journal of Heart Failure|July 11, 2006
The effect of testosterone on insulin sensitivity in men with heart failureChris J Malkin, T Hugh Jones, Kevin S Channer
American Heart Journal|February 26, 2003
Cytomegalovirus seropositivity, infectious burden, and coronary artery diseasePeter J Pugh, Christopher J Malkin, Kevin S Channer
Thorax|November 3, 2012
Focal pulmonary oedema: an unusual presentation of acute mitral regurgitationPaul D Morris, David R Warriner, Kevin S Channer
Nature|November 27, 2004
Replacement therapy, not recreational tonicRichard D Jones, T Hugh Jones, Kevin S Channer
Pageof 6